Virginia (State or other jurisdiction of incorporation) | 1-9819 (Commission File Number) | 52-1549373 (IRS Employer Identification No.) | |
4991 Lake Brook Drive, Suite 100 Glen Allen, Virginia (Address of principal executive offices) | 23060-9245 (Zip Code) | ||
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |
Exhibit No. | Description | |
99.1 | Press Release dated April 27, 2016 | |
DYNEX CAPITAL, INC. | |||
Date: | April 27, 2016 | By: | /s/ Stephen J. Benedetti |
Stephen J. Benedetti | |||
Executive Vice President, Chief Operating Officer and Chief Financial Officer | |||
FOR IMMEDIATE RELEASE | CONTACT: | Alison Griffin | |
April 27, 2016 | (804) 217-5897 | ||
• | Comprehensive income of $0.04 per common share comprised of net loss to common shareholders of $(0.81) per common share and other comprehensive income of $0.85 per common share |
• | Core net operating income per common share, a non-GAAP measure, of $0.22 |
• | Net interest spread of 1.97% and adjusted net interest spread, a non-GAAP measure, of 1.76% |
• | Book value per common share of $7.54 at March 31, 2016, a decline of 2.2% from $7.71 at December 31, 2015 |
• | Dividend declared of $0.21 per common share |
• | net interest income of $18.8 million |
• | net unrealized gains on changes in fair value of investments of $41.7 million due to declining interest rates, partially offset by unrealized losses due to credit spread widening |
• | net unrealized losses from changes in fair value of derivative instruments of $(41.5) million due to declining interest rate swap and Eurodollar rates as well as interest rate swap spread tightening |
• | realized losses of $(5.1) million on terminated derivative hedging instruments |
• | realized losses of $(3.9) million on MBS sales |
Three Months Ended | |||||||
($ in thousands) | March 31, 2016 | December 31, 2015 | |||||
Interest income | $ | 25,089 | $ | 25,522 | |||
Adjusted interest expense (1) | 7,963 | 6,429 | |||||
Adjusted net interest income (1) | 17,126 | 19,093 | |||||
Other income, net | 63 | 180 | |||||
General & administrative expenses | (4,092 | ) | (4,278 | ) | |||
Preferred stock dividends | (2,294 | ) | (2,294 | ) | |||
Core net operating income to common shareholders (1) | $ | 10,803 | $ | 12,701 | |||
• | lower adjusted net interest income due to a smaller average balance of interest earning assets, higher financing costs from repurchase agreement borrowings, and higher net periodic interest costs from hedges; |
• | partially offset by net prepayment compensation of $1.3 million principally on Agency CMBS, an increase of $0.8 million during the quarter |
($ in thousands) | RMBS | CMBS | CMBS IO | Total | |||||||||||
Balance at December 31, 2015 | $ | 1,663,732 | $ | 1,040,114 | $ | 789,855 | $ | 3,493,701 | |||||||
Purchases | — | — | 4,970 | 4,970 | |||||||||||
Principal payments | (75,008 | ) | (17,606 | ) | — | (92,614 | ) | ||||||||
Sales | (46,603 | ) | (34,868 | ) | — | (81,471 | ) | ||||||||
Net premium amortization | (3,863 | ) | (1,336 | ) | (32,336 | ) | (37,535 | ) | |||||||
Unrealized gain during the period | 11,333 | 30,172 | 196 | 41,701 | |||||||||||
Balance at March 31, 2016 | $ | 1,549,591 | $ | 1,016,476 | $ | 762,685 | $ | 3,328,752 | |||||||
Three Months Ended | |||||||||||||
March 31, 2016 | December 31, 2015 | ||||||||||||
($ in thousands) | Average Balance | Effective Yield (1) | Average Balance | Effective Yield (1) | |||||||||
RMBS: | |||||||||||||
Agency | $ | 1,549,079 | 1.84 | % | $ | 1,655,436 | 1.84 | % | |||||
Non-Agency | 64,025 | 3.62 | % | 68,799 | 3.62 | % | |||||||
1,613,104 | 1.91 | % | 1,724,235 | 1.91 | % | ||||||||
CMBS: | |||||||||||||
Agency | 879,727 | 3.01 | % | 912,606 | 2.96 | % | |||||||
Non-Agency | 137,866 | 5.37 | % | 164,881 | 4.48 | % | |||||||
1,017,593 | 3.33 | % | 1,077,487 | 3.19 | % | ||||||||
CMBS IO: | |||||||||||||
Agency | 413,100 | 3.80 | % | 411,797 | 3.86 | % | |||||||
Non-Agency | 362,288 | 3.92 | % | 360,579 | 3.94 | % | |||||||
775,388 | 3.85 | % | 772,376 | 3.90 | % | ||||||||
Total MBS Investments: | $ | 3,406,085 | 2.78 | % | $ | 3,574,098 | 2.73 | % | |||||
March 31, 2016 | December 31, 2015 | ||||||||||||
($ in thousands) | Balance | Weighted Average Rate | Balance | Weighted Average Rate | |||||||||
Agency RMBS | $ | 1,410,153 | 0.68 | % | $ | 1,439,436 | 0.47 | % | |||||
Non-Agency RMBS | 48,542 | 1.80 | % | 52,128 | 1.77 | % | |||||||
Agency CMBS | 516,893 | 0.68 | % | 301,427 | 0.49 | % | |||||||
Non-Agency CMBS | 101,358 | 1.36 | % | 126,378 | 1.26 | % | |||||||
Agency CMBS IO | 344,238 | 1.28 | % | 360,245 | 1.24 | % | |||||||
Non-Agency CMBS IO | 294,392 | 1.36 | % | 302,771 | 1.33 | % | |||||||
Securitization financing bonds | 6,443 | 1.79 | % | 7,035 | 1.65 | % | |||||||
Total repurchase agreement financing | 2,722,019 | 0.88 | % | 2,589,420 | 0.75 | % | |||||||
FHLB advances collateralized with Agency CMBS | $ | 263,000 | 0.51 | % | $ | 520,000 | 0.40 | % | |||||
($ in thousands) | Notional Balance | Rate (1) | ||||
Balance of effective interest rate swaps at December 31, 2015 | $ | 480,000 | 1.06% | |||
Effective interest rate swaps added | 1,000,000 | 0.69% | ||||
Previously forward-starting interest rate swaps (2) | 325,000 | 1.94% | ||||
Interest rate swaps terminated | (1,000,000 | ) | 0.69% | |||
Balance of effective interest rate swaps at March 31, 2016 | $ | 805,000 | 1.41% | |||
($ in thousands) | Realized Gains (Losses) | Change in Fair Value of Derivative Instruments | Periodic Interest Costs (1) | Gain (Loss) on Derivative Instruments, Net | |||||||||||
Receive-fixed interest rate swaps | $ | — | $ | 9,111 | $ | 1,423 | $ | 10,534 | |||||||
Pay-fixed interest rate swaps | (5,082 | ) | (38,427 | ) | (3,103 | ) | (46,612 | ) | |||||||
Eurodollar futures | — | (12,186 | ) | — | (12,186 | ) | |||||||||
Total | $ | (5,082 | ) | $ | (41,502 | ) | $ | (1,680 | ) | $ | (48,264 | ) | |||
(1) | Amounts represent interest earned or incurred related to interest rate swaps effective during the quarter. |
# | # | # |
March 31, 2016 | December 31, 2015 | ||||||
ASSETS | (unaudited) | ||||||
Mortgage-backed securities | $ | 3,328,752 | $ | 3,493,701 | |||
Mortgage loans held for investment, net | 23,271 | 24,145 | |||||
Investment in limited partnership | 98 | 10,835 | |||||
Investment in FHLB stock | 11,475 | 11,475 | |||||
Cash and cash equivalents | 82,940 | 33,935 | |||||
Restricted cash | 86,864 | 51,190 | |||||
Derivative assets | 14,845 | 7,835 | |||||
Principal receivable on investments | 6,382 | 6,193 | |||||
Accrued interest receivable | 22,151 | 22,764 | |||||
Other assets, net | 7,310 | 7,975 | |||||
Total assets | $ | 3,584,088 | $ | 3,670,048 | |||
LIABILITIES AND SHAREHOLDERS’ EQUITY | |||||||
Liabilities: | |||||||
Repurchase agreements | $ | 2,722,019 | $ | 2,589,420 | |||
FHLB advances | 263,000 | 520,000 | |||||
Non-recourse collateralized financing | 8,140 | 8,442 | |||||
Derivative liabilities | 90,487 | 41,205 | |||||
Accrued interest payable | 2,243 | 1,743 | |||||
Accrued dividends payable | 12,247 | 13,709 | |||||
Other liabilities | 2,153 | 3,504 | |||||
Total liabilities | 3,100,289 | 3,178,023 | |||||
Shareholders’ equity: | |||||||
Preferred stock, par value $.01 per share, 8.5% Series A Cumulative Redeemable; 8,000,000 shares authorized; 2,300,000 shares issued and outstanding ($57,500 aggregate liquidation preference) | $ | 55,407 | $ | 55,407 | |||
Preferred stock, par value $.01 per share, 7.625% Series B Cumulative Redeemable; 7,000,000 shares authorized; 2,250,000 shares issued and outstanding($56,250 aggregate liquidation preference) | 54,251 | 54,251 | |||||
Common stock, par value $.01 per share, 200,000,000 shares authorized; 49,095,797 and 49,047,335 shares issued and outstanding, respectively | 491 | 490 | |||||
Additional paid-in capital | 725,438 | 725,358 | |||||
Accumulated other comprehensive income (loss) | 28,960 | (12,768 | ) | ||||
Accumulated deficit | (380,748 | ) | (330,713 | ) | |||
Total shareholders' equity | 483,799 | 492,025 | |||||
Total liabilities and shareholders’ equity | $ | 3,584,088 | $ | 3,670,048 | |||
Book value per common share | $ | 7.54 | $ | 7.71 | |||
Three Months Ended | |||||||
March 31, | |||||||
2016 | 2015 | ||||||
(unaudited) | (unaudited) | ||||||
Interest income | 25,089 | 24,099 | |||||
Interest expense | 6,310 | 5,371 | |||||
Net interest income | 18,779 | 18,728 | |||||
Loss on derivative instruments, net | (48,264 | ) | (25,323 | ) | |||
(Loss) gain on sale of investments, net | (3,941 | ) | 1,308 | ||||
Fair value adjustments, net | 24 | 39 | |||||
Other income, net | 63 | 34 | |||||
General and administrative expenses: | |||||||
Compensation and benefits | (2,219 | ) | (2,117 | ) | |||
Other general and administrative | (1,873 | ) | (2,141 | ) | |||
Net loss | (37,431 | ) | (9,472 | ) | |||
Preferred stock dividends | (2,294 | ) | (2,294 | ) | |||
Net loss to common shareholders | $ | (39,725 | ) | $ | (11,766 | ) | |
Other comprehensive income: | |||||||
Change in net unrealized gain on available-for-sale investments | $ | 37,760 | $ | 23,304 | |||
Reclassification adjustment for loss (gain) on sale of investments, net | 3,941 | (1,308 | ) | ||||
Reclassification adjustment for de-designated cash flow hedges | 27 | 1,057 | |||||
Total other comprehensive income | 41,728 | 23,053 | |||||
Comprehensive income to common shareholders | $ | 2,003 | $ | 11,287 | |||
Net loss per common share-basic and diluted | $ | (0.81 | ) | $ | (0.21 | ) | |
Weighted average common shares | 49,041 | 54,800 | |||||
1Q2016 | 4Q2015 | 3Q2015 | 2Q2015 | 1Q2015 | |||||||||||||||
Net (loss) income per common share | $ | (0.81 | ) | $ | 0.61 | $ | (0.74 | ) | $ | 0.52 | $ | (0.21 | ) | ||||||
Core net operating income per common share (1) | $ | 0.22 | $ | 0.25 | $ | 0.24 | $ | 0.21 | $ | 0.23 | |||||||||
Comprehensive income (loss) per common share | $ | 0.04 | $ | (0.30 | ) | $ | (0.22 | ) | $ | (0.21 | ) | $ | 0.21 | ||||||
Dividends per common share | $ | 0.21 | $ | 0.24 | $ | 0.24 | $ | 0.24 | $ | 0.24 | |||||||||
Book value per common share, end of period | $ | 7.54 | $ | 7.71 | $ | 8.19 | $ | 8.53 | $ | 8.96 | |||||||||
Leverage at period end (2) | 6.4 | x | 6.5 | x | 6.4 | x | 6.2 | x | 5.7 | x | |||||||||
Average interest earning assets | $ | 3,429,875 | $ | 3,598,748 | $ | 3,818,140 | $ | 3,748,536 | $ | 3,577,644 | |||||||||
Average interest bearing liabilities | $ | 3,095,490 | $ | 3,237,574 | $ | 3,405,850 | $ | 3,320,760 | $ | 3,111,783 | |||||||||
Net interest income | $ | 18,779 | $ | 19,689 | $ | 20,237 | $ | 18,985 | $ | 18,728 | |||||||||
Adjusted net interest income (1) | $ | 17,126 | $ | 19,093 | $ | 19,342 | $ | 18,049 | $ | 18,923 | |||||||||
Effective yield by investment type (3): | |||||||||||||||||||
RMBS | 1.91 | % | 1.91 | % | 1.76 | % | 1.82 | % | 1.88 | % | |||||||||
CMBS | 3.33 | % | 3.19 | % | 3.36 | % | 3.38 | % | 3.70 | % | |||||||||
CMBS IO | 3.85 | % | 3.90 | % | 3.85 | % | 3.86 | % | 3.83 | % | |||||||||
Mortgage loans held for investment | 3.82 | % | 3.96 | % | 4.37 | % | 4.24 | % | 4.13 | % | |||||||||
Effective yield-total portfolio | 2.78 | % | 2.74 | % | 2.69 | % | 2.63 | % | 2.62 | % | |||||||||
Cost of funds (4) | 0.81 | % | 0.70 | % | 0.67 | % | 0.66 | % | 0.69 | % | |||||||||
Net interest spread | 1.97 | % | 2.04 | % | 2.02 | % | 1.97 | % | 1.93 | % | |||||||||
Adjusted cost of funds (1) | 1.02 | % | 0.78 | % | 0.78 | % | 0.77 | % | 0.66 | % | |||||||||
Adjusted net interest spread (1) | 1.76 | % | 1.96 | % | 1.91 | % | 1.86 | % | 1.96 | % | |||||||||
(1) | Non-GAAP financial measures are reconciled in the supplement to this release. |
(2) | Also commonly referred to by the Company as "overall leverage" and is calculated by dividing total liabilities by total shareholders' equity. |
(3) | Effective yield is weighted by the average balance of investments which is calculated using daily amortized cost basis. |
(4) | Percentages shown are based on annualized interest expense amounts divided by average interest bearing liabilities. |
Three Months Ended | |||||||||||||||||||
March 31, 2016 | December 31, 2015 | September 30, 2015 | June 30, 2015 | March 31, 2015 | |||||||||||||||
GAAP net (loss) income to common shareholders | $ | (39,725 | ) | $ | 30,237 | $ | (39,271 | ) | $ | 28,168 | $ | (11,766 | ) | ||||||
Less: | |||||||||||||||||||
Amortization of de-designated cash flow hedges (1) | 27 | 727 | 857 | 857 | 1,057 | ||||||||||||||
Change in fair value of derivative instruments, net (2) | 46,584 | (19,177 | ) | 50,997 | (18,883 | ) | 24,461 | ||||||||||||
Loss (gain) on sale of investments, net | 3,941 | 908 | (113 | ) | 1,491 | (1,308 | ) | ||||||||||||
Fair value adjustments, net | (24 | ) | 6 | (16 | ) | (20 | ) | (39 | ) | ||||||||||
Core net operating income to common shareholders | $ | 10,803 | $ | 12,701 | $ | 12,454 | $ | 11,613 | $ | 12,405 | |||||||||
Weighted average common shares | 49,041 | 49,299 | 52,777 | 54,574 | 54,800 | ||||||||||||||
Core net operating income per common share | $ | 0.22 | $ | 0.25 | $ | 0.24 | $ | 0.21 | $ | 0.23 | |||||||||
(2) | Amount includes any realized gains (losses) recognized during the period presented and excludes net periodic interest costs of derivative instruments. |
Three Months Ended | ||||||||||||||||||||
March 31, 2016 | December 31, 2015 | September 30, 2015 | ||||||||||||||||||
Amount | Yield/Rate | Amount | Yield/Rate | Amount | Yield/Rate | |||||||||||||||
GAAP interest income | $ | 25,089 | 2.78 | % | $ | 25,522 | 2.74 | % | $ | 26,096 | 2.69 | % | ||||||||
GAAP interest expense/cost of funds (1) | 6,310 | 0.81 | % | 5,833 | 0.70 | % | 5,859 | 0.67 | % | |||||||||||
Net interest income/spread | 18,779 | 1.97 | % | 19,689 | 2.04 | % | 20,237 | 2.02 | % | |||||||||||
GAAP interest expense/cost of funds (1) | $ | 6,310 | 0.81 | % | $ | 5,833 | 0.70 | % | $ | 5,859 | 0.67 | % | ||||||||
Less: amortization of de-designated cash flow hedges (2) | (27 | ) | — | % | (727 | ) | (0.08 | )% | (857 | ) | (0.10 | )% | ||||||||
Add: net periodic interest costs of derivative instruments | 1,680 | 0.21 | % | 1,323 | 0.16 | % | 1,752 | 0.21 | % | |||||||||||
Adjusted interest expense/ adjusted cost of funds | 7,963 | 1.02 | % | 6,429 | 0.78 | % | 6,754 | 0.78 | % | |||||||||||
Adjusted net interest income/spread | $ | 17,126 | 1.76 | % | $ | 19,093 | 1.96 | % | $ | 19,342 | 1.91 | % | ||||||||
Three Months Ended | ||||||||||||||||||||
June 30, 2015 | March 31, 2015 | |||||||||||||||||||
Amount | Yield/Rate | Amount | Yield/Rate | |||||||||||||||||
GAAP interest income | $ | 24,527 | 2.63 | % | $ | 24,099 | 2.62 | % | ||||||||||||
GAAP interest expense/cost of funds (1) | 5,542 | 0.66 | % | 5,371 | 0.69 | % | ||||||||||||||
Net interest income/spread | 18,985 | 1.97 | % | 18,728 | 1.93 | % | ||||||||||||||
GAAP interest expense/cost of funds (1) | $ | 5,542 | 0.66 | % | $ | 5,371 | 0.69 | % | ||||||||||||
Less: amortization of de-designated cash flow hedges (2) | (857 | ) | (0.10 | )% | (1,057 | ) | (0.14 | )% | ||||||||||||
Add: net periodic interest costs of derivative instruments | 1,793 | 0.21 | % | 862 | 0.11 | % | ||||||||||||||
Adjusted interest expense/ adjusted cost of funds | 6,478 | 0.77 | % | 5,176 | 0.66 | % | ||||||||||||||
Adjusted net interest income/spread | $ | 18,049 | 1.86 | % | $ | 18,923 | 1.96 | % | ||||||||||||
(1) | Percentages shown are based on annualized interest expense amounts divided by average interest bearing liabilities. |
(2) | Amount recorded as a portion of "interest expense" in accordance with GAAP related to the amortization of the balance remaining in accumulated other comprehensive loss as of June 30, 2013 as a result of the Company's discontinuation of hedge accounting. |